The FDA has just approved the very first prescription medication to improve eyelash length and fullness! LATISSE (bimatoprost ophthalmic solution) 0.03% is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
The FDA has just approved the very first prescription medication to improve eyelash length and fullness! LATISSE (bimatoprost ophthalmic solution) 0.03% is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
The FDA has just approved the very first prescription medication to improve eyelash length and fullness! LATISSE (bimatoprost ophthalmic solution) 0.03% is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
Introductory Price: $120 per kit Save an additional $20 when purchased with BOTOX® or Juvederm™ injection the same day. Expires 3/31/09.
Introductory Price: $120 per kit
Save an additional $20 when purchased with BOTOX® or Juvederm™ injection the same day.
Expires 3/31/09.
Introductory Price: $120 per kit Save an additional $20 when purchased with BOTOX® or Juvederm™ injection the same day. Expires 3/31/09.
See the results and learn more at www.latisse.com
See the results and learn more at www.latisse.com
See the results and learn more at www.latisse.com